Dispelling A Few Common Myths About Journal Citation Impacts

Dispelling A Few Common Myths About Journal Citation Impacts Author: Eugene Garfield The Scientist,Vol.11(3),p.11, February 3, 1997           Last October I participated in a conference on research assessment in Capri, Italy. The various discussions and presentations at this meeting reminded me that there are still widespread misunderstandings-indeed, myths-about citation analysis, especially with respect to journal impact. For those readers who are not afic

Written byEugene Garfield
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Last October I participated in a conference on research assessment in Capri, Italy. The various discussions and presentations at this meeting reminded me that there are still widespread misunderstandings-indeed, myths-about citation analysis, especially with respect to journal impact. For those readers who are not aficionados of citation analysis, journal impact factors as used in the Institute for Scientific Information's (ISI's) Journal Citation Reports are a simple ratio of citations and papers. They are calculated by dividing the number of current-year citations (for example, 1997) to a journal's papers published in the previous two years (that is, 1996 and 1995) by the combined total of these papers.

Journal impact factors are used for a variety of purposes. For example, librarians may consider impact factors, as well as several other important criteria, in their decisions on which journals to include in their collections. Journal impact has also become a staple in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies